Long-Term Outcomes after Rotational Atherectomy for Calcified Chronic Total Occlusion versus Nonchronic Total Occlusion Coronary Lesions.


Journal

Journal of interventional cardiology
ISSN: 1540-8183
Titre abrégé: J Interv Cardiol
Pays: United States
ID NLM: 8907826

Informations de publication

Date de publication:
2022
Historique:
received: 13 07 2021
revised: 28 09 2021
accepted: 03 12 2022
entrez: 13 1 2023
pubmed: 14 1 2023
medline: 17 1 2023
Statut: epublish

Résumé

The role of rotational atherectomy (RA) in contemporary percutaneous coronary intervention (PCI) is expanding to include certain chronic total occlusion (CTO) lesions. However, the long-term outcome of RA in CTOs is still unclear. To investigate in-hospital and long-term outcomes after RA for CTO compared to non-CTO calcified lesions. Moreover, this report evaluates the role of the elective RA approach in calcified CTOs. This study enrolled 812 patients (869 lesions; CTO, Compared to non-CTO, RA for CTO can be performed with a high procedural success rate and comparable in-hospital outcomes. Apart from higher cardiac mortality in the CTO group, the long-term outcomes are comparable in both groups. Elective RA is a feasible and beneficial approach to be used in CTO intervention.

Sections du résumé

Background UNASSIGNED
The role of rotational atherectomy (RA) in contemporary percutaneous coronary intervention (PCI) is expanding to include certain chronic total occlusion (CTO) lesions. However, the long-term outcome of RA in CTOs is still unclear.
Objective UNASSIGNED
To investigate in-hospital and long-term outcomes after RA for CTO compared to non-CTO calcified lesions. Moreover, this report evaluates the role of the elective RA approach in calcified CTOs.
Methods and Results UNASSIGNED
This study enrolled 812 patients (869 lesions; CTO,
Conclusion UNASSIGNED
Compared to non-CTO, RA for CTO can be performed with a high procedural success rate and comparable in-hospital outcomes. Apart from higher cardiac mortality in the CTO group, the long-term outcomes are comparable in both groups. Elective RA is a feasible and beneficial approach to be used in CTO intervention.

Identifiants

pubmed: 36636261
doi: 10.1155/2022/2593189
pmc: PMC9810405
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2593189

Informations de copyright

Copyright © 2022 Karim Elbasha et al.

Déclaration de conflit d'intérêts

M. Abdel-Wahab and G. Richardt report receiving an institutional research grant from Biotronik and St. Jude Medical. G. Richardt is an advisory board member for Abbott Vascular and Boston Scientific and reports receiving lecture fees from Abbott Vascular, Biotronik, Boston Scientific and Edwards Lifesciences. R. Toelg reports receiving honoraria for advisory board membership and lectures from Abbott Vascular and Biotronik. R. Hemetsberger received speaker's honoraria from Boston Scientific. A. Allali is a proctor for Boston Scientific. The other authors declare that they have no conflicts of interest.

Références

Catheter Cardiovasc Interv. 2010 Sep 1;76(3):366-71
pubmed: 20839349
Catheter Cardiovasc Interv. 2021 Jun 1;97(7):1407-1416
pubmed: 32776696
Eur Heart J. 2019 Jan 14;40(3):237-269
pubmed: 30165617
EuroIntervention. 2012 May 15;8(1):139-45
pubmed: 22580257
J Invasive Cardiol. 2013 Oct;25(10):486-91
pubmed: 24088420
EuroIntervention. 2018 Dec 07;14(11):e1192-e1198
pubmed: 30175961
JACC Cardiovasc Interv. 2011 Feb;4(2):213-21
pubmed: 21349461
Circulation. 2018 Jun 12;137(24):2635-2650
pubmed: 29891620
Am J Cardiol. 2019 May 1;123(9):1422-1428
pubmed: 30798947
Ther Clin Risk Manag. 2020 Feb 18;16:95-101
pubmed: 32110027
Catheter Cardiovasc Interv. 2018 Mar 1;91(4):657-666
pubmed: 29359452
EuroIntervention. 2015 May;11(1):30-6
pubmed: 25982648
Catheter Cardiovasc Interv. 2014 Oct 1;84(4):646-51
pubmed: 24585508
J Am Coll Cardiol. 2002 Apr 3;39(7):1096-103
pubmed: 11923031
J Interv Cardiol. 2018 Aug;31(4):458-464
pubmed: 29315803
Circulation. 1995 Apr 1;91(7):1959-65
pubmed: 7895353
J Clin Med. 2020 May 02;9(5):
pubmed: 32370276
Catheter Cardiovasc Interv. 2017 Jul;90(1):12-20
pubmed: 27650935
Circulation. 1994 Dec;90(6):2725-30
pubmed: 7994814
Am J Cardiol. 2017 Jul 1;120(1):40-46
pubmed: 28499595
J Interv Cardiol. 2017 Apr;30(2):124-133
pubmed: 27990696
Catheter Cardiovasc Interv. 2017 Apr;89(5):820-828
pubmed: 28029214
Circ Cardiovasc Interv. 2018 Oct;11(10):e007362
pubmed: 30354649

Auteurs

Karim Elbasha (K)

Cardiology Department, Heart Center Segeberger Kliniken GmbH, Bad Segeberg, Germany.
Cardiology Department, Zagazig University, Sharkia, Egypt.

Nader Mankerious (N)

Cardiology Department, Heart Center Segeberger Kliniken GmbH, Bad Segeberg, Germany.

Mohamed Alawady (M)

Cardiology Department, Zagazig University, Sharkia, Egypt.

Ghada Ibrahim (G)

Cardiology Department, Zagazig University, Sharkia, Egypt.

Radwa Abdullah (R)

Cardiology Department, Zagazig University, Sharkia, Egypt.

Mohamed Abdel-Wahab (M)

Cardiology Department, Heart Center Leipzig at the University of Leipzig, Leipzig, Germany.

Rayyan Hemetsberger (R)

Cardiology Department, Heart Center Segeberger Kliniken GmbH, Bad Segeberg, Germany.
Department of Cardiology, Internal Medicine II, Medical University of Vienna, Austria.

Ralph Toelg (R)

Cardiology Department, Heart Center Segeberger Kliniken GmbH, Bad Segeberg, Germany.

Gert Richardt (G)

Cardiology Department, Heart Center Segeberger Kliniken GmbH, Bad Segeberg, Germany.

Abdelhakim Allali (A)

Cardiology Department, Heart Center Segeberger Kliniken GmbH, Bad Segeberg, Germany.
Medical Clinic II, University Heart Center Lubeck, Lubeck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH